Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: May 30, 2024
DUBLIN, May 30, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences:
